Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$144M |
| 2 |
Cisco
CSCO
|
+$123M |
| 3 |
Moderna
MRNA
|
+$120M |
| 4 |
JPMorgan Chase
JPM
|
+$95.4M |
| 5 |
FedEx
FDX
|
+$86.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$124M |
| 2 |
Mastercard
MA
|
+$101M |
| 3 |
Home Depot
HD
|
+$95.7M |
| 4 |
Amazon
AMZN
|
+$74.1M |
| 5 |
Eli Lilly
LLY
|
+$72.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.71% |
| 2 | Healthcare | 14.72% |
| 3 | Consumer Discretionary | 14.64% |
| 4 | Industrials | 11.02% |
| 5 | Consumer Staples | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
StoneX
SNEX
$8.21B
| $2.83M | ﹤0.01% |
219,247
-26,107
| -11% | -$315K |
|
1027
National Healthcare
NHC
$3.54B
| $2.82M | ﹤0.01% |
36,238
-1,589
| -4% | -$112K |
|
1028
HubSpot
HUBS
$11.9B
| $2.82M | ﹤0.01% |
6,244
-3,903
| -38% | -$1.71M |
|
1029
Okta
OKTA
$22.8B
| $2.82M | ﹤0.01% |
12,877
-14,658
| -53% | -$3.68M |
|
1030
Halliburton
HAL
$28.6B
| $2.81M | ﹤0.01% |
131,125
+112,592
| +608% | +$2.36M |
|
1031
Nasdaq
NDAQ
$55.3B
| $2.81M | ﹤0.01% |
57,234
+14,091
| +33% | +$669K |
|
1032
Acacia Research
ACTG
$443M
| $2.81M | ﹤0.01% |
+422,840
| New | +$2.66M |
|
1033
Manitowoc
MTW
$699M
| $2.8M | ﹤0.01% |
135,629
-133,987
| -50% | -$2.22M |
|
1034
Fate Therapeutics
FATE
$296M
| $2.79M | ﹤0.01% |
33,847
-1,475
| -4% | -$141K |
|
1035
GoDaddy
GDDY
$12.6B
| $2.79M | ﹤0.01% |
35,921
+6,350
| +21% | +$511K |
|
1036
Scansource
SCSC
$1.11B
| $2.79M | ﹤0.01% |
93,082
-18,249
| -16% | -$529K |
|
|
DOC
1037
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $2.78M | ﹤0.01% |
157,797
+127,263
| +417% | +$2.26M |
|
|
INOV
1038
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $2.78M | ﹤0.01% |
96,537
-65,048
| -40% | -$1.67M |
|
1039
Expedia Group
EXPE
$40.1B
| $2.75M | ﹤0.01% |
16,004
+6,166
| +63% | +$949K |
|
1040
Inspire Medical Systems
INSP
$1.78B
| $2.75M | ﹤0.01% |
13,307
+1,229
| +10% | +$261K |
|
1041
Hackett Group
HCKT
$278M
| $2.75M | ﹤0.01% |
167,780
-64,199
| -28% | -$994K |
|
1042
Medifast
MED
$135M
| $2.75M | ﹤0.01% |
12,966
-762
| -6% | -$182K |
|
|
NXGN
1043
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.74M | ﹤0.01% |
151,475
-26,162
| -15% | -$516K |
|
1044
Artisan Partners
APAM
$3.03B
| $2.74M | ﹤0.01% |
52,522
-14,756
| -22% | -$753K |
|
1045
Coca-Cola Consolidated
COKE
$12.8B
| $2.73M | ﹤0.01% |
94,620
+5,400
| +6% | +$148K |
|
1046
Diodes
DIOD
$4.17B
| $2.73M | ﹤0.01% |
34,215
-12,841
| -27% | -$1.02M |
|
1047
Ennis
EBF
$540M
| $2.73M | ﹤0.01% |
127,958
-2,271
| -2% | -$45K |
|
1048
Black Hills Corp
BKH
$5.55B
| $2.7M | ﹤0.01% |
40,402
+7,111
| +21% | +$442K |
|
1049
Coca-Cola Femsa
KOF
$24.2B
| $2.69M | ﹤0.01% |
58,171
+33,417
| +135% | +$1.53M |
|
1050
Sally Beauty Holdings
SBH
$1.52B
| $2.68M | ﹤0.01% |
133,118
-1,339,850
| -91% | -$22.4M |
|
Similar funds
Cliff Asness's Q1 2021 Portfolio in Review
As of Q1 2021, Cliff Asness held 2,331 positions worth $61.1B, up 8.4% from $56.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Cliff Asness's Q1 2021 filing shows 154 new, 918 increased, 1,058 reduced and 154 closed positions. Its largest new stake was Janus Henderson: 506,382 shares worth $15.8M. The largest sale was Microsoft, an estimated $124M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Cliff Asness's largest Q1 2021 buy was Janus Henderson: 506,382 shares worth $15.8M.
- Cliff Asness added most to Thermo Fisher Scientific in Q1 2021, an estimated $144M increase.
- Cliff Asness's biggest Q1 2021 reduction was Microsoft, cutting an estimated $124M.
- Cliff Asness fully exited State Street SPDR S&P 500 ETF Trust in Q1 2021, selling an estimated $39.7M.
- Cliff Asness's ten largest holdings make up 18% of its $61.1B portfolio in Q1 2021.
- Cliff Asness opened 154 new positions and closed 154 in Q1 2021.
- Cliff Asness's portfolio value rose 8.4% quarter-over-quarter to $61.1B.
Based on AQR Capital Management's 13F filing for Q1 2021, filed 17 May 2021.